title: Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding.
abstract: Squirrel monkeys have high circulating cortisol to compensate for expression of low-affinity glucocorticoid receptors (GRs). We have demonstrated that the FK506-binding immunophilin FKBP51 is elevated in squirrel monkey lymphocytes (SML) and, in preliminary studies, have shown that squirrel monkey FKBP51 is inhibitory to GR binding. In this report, we have demonstrated that elevated FKBP51 is the unequivocal cause of glucocorticoid resistance in SML in the following ways: 1) FK506 increased GR binding in cytosol from SML in a concentration-dependent manner, an effect reproduced by rapamycin but not cyclosporin A. The apparent K6 (6.1 nM) and rank-order of steroid displacement of [3H]dexamethasone binding in FK506-treated SML cytosol are characteristic of high-affinity GR binding. 2) cytosol from COS-7 cells expressing squirrel monkey FKBP51 inhibited GR binding in cytosol from human lymphocytes by 74%. Cytosol from COS-7 cells expressing human FKBP51 inhibited GR binding by 23%. 3) expression of squirrel monkey FKBP51 increased the median effective concentration (EC50) for dexamethasone in GR transactivation studies in COS-7 cells by approximately 17-fold, compared with the EC50 in control cells. The expression of human FKBP51 increased the EC50 for dexamethasone in COS-7 cells by less than 3-fold, compared with control. Squirrel monkey FKBP51 shares 94% overall amino acid homology with human FKBP51, with 92% and 99% homology with human FKBP51 in the peptidyl-prolyl isomerase and the tetratricopeptide repeat domains, respectively. Amino acid differences in the more variable N- or C-terminal regions or in regions which join the highly homologous functional domains may be responsible for its more potent inhibitory activity.
authors.affiliation: Department of Pharmacology, University of South Alabama College of Medicine, Mobile 36688, USA.
authors.forename: W B
authors.initials: WB
authors.lastname: Denny
authors.forename: D L
authors.initials: DL
authors.lastname: Valentine
authors.forename: P D
authors.initials: PD
authors.lastname: Reynolds
authors.forename: D F
authors.initials: DF
authors.lastname: Smith
authors.forename: J G
authors.initials: JG
authors.lastname: Scammell
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001402:B-Lymphocytes / Q000737:chemistry; D019556:COS Cells; D002460:Cell Line; D018076:DNA, Complementary / Q000737:chemistry; D003907:Dexamethasone / Q000378:metabolism; D015870:Gene Expression; D005938:Glucocorticoids / Q000378:metabolism; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D012453:Saimiri / Q000235:genetics; D017385:Sequence Homology; D022021:Tacrolimus Binding Proteins / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*; D014162:Transfection; D014316:Tritium; D000099159:Tacrolimus Binding Protein 5
chemical_list: D018076:DNA, Complementary; D003907:Dexamethasone; D005938:Glucocorticoids; D011965:Receptors, Glucocorticoid; D022021:Tacrolimus Binding Proteins; D014316:Tritium; D000099159:Tacrolimus Binding Protein 5